Arrowhead Pharmaceuticals ARWR
NASDAQ ARWR
$65.84 -0.41 (-0.62%)
As of: Sep 30, 2026 · 9:49 AM EDT

Arrowhead Pharmaceuticals (ARWR) EV to EBITDA (2019 - 2025)

Updated

Arrowhead Pharmaceuticals' (ARWR) EV to EBITDA came in at 25.18 for fiscal Q1 2026 (quarter ended Dec 31, 2025), down 19.0% from the prior quarter.

Analysis

Arrowhead Pharmaceuticals (ARWR) EV to EBITDA (2019 - 2025) Analysis & Trends

For the trailing twelve months through Dec 31, 2025, EV to EBITDA at Arrowhead Pharmaceuticals was 16.22; for FY2025 (ended Sep 30, 2025), it was 31.06.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Arrowhead Pharmaceuticals 9.24 Bn 4.02 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 25.18
Sep 30, 2025 31.06
Mar 31, 2020 447.05
Dec 31, 2019 118.42
Sep 30, 2019 37.06
Jun 30, 2019 50.83
Mar 31, 2019 142.89
API Access

Arrowhead Pharmaceuticals EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ARWR&period=max&api_key=YOUR_API_KEY